Holen Sie sich die Stockscreener-App
547.93
0.01%
-0.03
Handel nachbörslich:
558.42
10.49
+1.91%
Regeneron Pharmaceuticals Inc Aktie (REGN) Neueste Nachrichten
UBS Raises Regeneron (REGN) Price Target, Maintains Neutral Rating - MSN
Retinal Vein Occlusion Market Trends: Surge in Anti-VEGF - openPR.com
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Grandfield & Dodd LLC - MarketBeat
Unexpected Trends Reshaping the Diabetic Retinopathy Market - openPR.com
Arizona State Retirement System Raises Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron and Intellia’s Gene Therapy Study: A Potential Game-Changer for Hemophilia B - TipRanks
CenterBook Partners LP Sells 10,270 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Sumitomo Life Insurance Co. Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Concord Asset Management LLC VA Has $1.33 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Leo Wealth LLC Has $748,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Envestnet Asset Management Inc. Purchases 25,589 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s Bid - MSN
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00 at UBS Group - MarketBeat
ANGPTL3 Therapy Market Rises with Focus on Cardiovascular - openPR.com
OVERSEA CHINESE BANKING Corp Ltd Invests $30.17 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
685 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Asahi Life Asset Management CO. LTD. - MarketBeat
Slow Capital Inc. Raises Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Cutter & CO Brokerage Inc. - MarketBeat
710 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by MQS Management LLC - MarketBeat
New York State Common Retirement Fund Sells 6,846 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Wet Age-Related Macular Degeneration (Wet AMD) Market Analysis Report 2025-2035 | Long-Acting Therapies, AI Diagnostics, and Personalized Medicine Set to Redefine the Future Landscape - GlobeNewswire Inc.
Rehmann Capital Advisory Group Acquires 770 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
FDA Action Alert: Roche, GSK, Regeneron, More - BioSpace
Morgan Stanley Issues Pessimistic Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat
Oxbow Advisors LLC Purchases New Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
UBS Lowers Price Target On Regeneron Pharmaceuticals, Inc. (REGN). - MSN
SteelPeak Wealth LLC Has $2.29 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Research Analysts Set Expectations for REGN FY2026 Earnings - MarketBeat
Accelerated FDA Approval of Lynozyfic May Change the Case for Investing in Regeneron (REGN) - simplywall.st
Amgen Eyes New Trial After Regeneron's $407M Antitrust Win - Law360
Lobbying Update: $30,000 of REGENERON PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
2 Firms Tapped To Lead Regeneron Investor Suit - Law360
UBS Raises Price Target on Regeneron Pharmaceuticals to $584 From $560, Keeps Neutral Rating - MarketScreener
Leerink Partnrs Issues Negative Estimate for REGN Earnings - MarketBeat
Regeneron (REGN) Scores FDA Approval, JP Morgan Reaffirms $800 Price Target - Yahoo Finance
Impax Asset Management Group plc Sells 1,385 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Assessing Regeneron Pharmaceuticals: Insights From 26 Financial Analysts - Nasdaq
Mcdonald Capital Investors Inc. CA Acquires 26,593 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals: My Highest Conviction Pharma Pick For 2025 (NASDAQ:REGN) - Seeking Alpha
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Nisa Investment Advisors LLC - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat
Bank of New York Mellon Corp Increases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron’s Blockbuster Dupixent Faces a New Rival - Barron's
DekaBank Deutsche Girozentrale Purchases 9,969 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron’s Lynozyfic Gains Accelerated FDA Approval for Multiple Myeloma - Insider Monkey
Could Apogee Rival Regeneron/Sanofi, Lilly After Phase II Eczema Data Win? - insights.citeline.com
GF Fund Management CO. LTD. Has $20.17 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Regeneron Pharmaceuticals (REGN) Announces Approval of Dupixent in the US - Insider Monkey
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by First Horizon Advisors Inc. - MarketBeat
Allspring Global Investments Holdings LLC Has $24.45 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by New York State Teachers Retirement System - MarketBeat
August 22nd Options Now Available For Regeneron Pharmaceuticals, Inc. (REGN) - Nasdaq
Regeneron Pharmaceuticals (REGN) and Sanofi Announce Approval of Dupixent® By US FDA - Insider Monkey
Regeneron Pharmaceuticals (NASDAQ:REGN) Cut to Hold at Argus - MarketBeat
KBC Group NV Purchases 12,793 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Diversified Trust Co Acquires 544 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $56.71 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Adams Diversified Equity Fund Inc. Sells 2,000 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Chevy Chase Trust Holdings LLC - MarketBeat
Regeneron Sets Q2 2025 Earnings Date: What Investors Should Watch Before August 1 Report - Stock Titan
Regeneron: Negative Scenario Is Being Realized (Rating Downgrade) (NASDAQ:REGN) - Seeking Alpha
3.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):